Crux Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$444K Sell
6,596
-404
-6% -$26.9K 0.15% 128
2026
Q1
$440K Buy
7,000
+227
+3% +$15.8K 0.17% 121
2025
Q4
$450K Buy
+6,773
New +$438K 0.17% 116
2025
Q1
Sell
-3,151
Closed -$245K 170
2024
Q4
$245K Buy
+3,151
New +$233K 0.14% 135

Other funds holding DXCM

Crux Wealth Advisors's DXCM Position: Q2 2026 in Review

Crux Wealth Advisors reduced its DexCom (DXCM) stake by 5.8% in Q2 2026, selling an estimated $26.9K and leaving 6,596 shares worth $444K. The position accounts for 0.15% of the portfolio, ranked #128.

Crux Wealth Advisors first reported a position in DXCM in Q4 2024 and has held it in 4 quarters since. The position peaked at $450K in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Crux Wealth Advisors held 6,596 shares of DexCom worth $444K as of Q2 2026.
  • Crux Wealth Advisors sold 404 DexCom shares in Q2 2026, an estimated $26.9K.
  • DexCom made up 0.15% of Crux Wealth Advisors's portfolio in Q2 2026, its #128 holding.
  • Crux Wealth Advisors first reported a position in DexCom in Q4 2024 and has held it in 4 quarters since.
  • Crux Wealth Advisors's DexCom position peaked at $450K in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Crux Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.